Use of right orbitofrontal repetitive transcranial magnetic stimulation (rTMS) augmentation for treatment-refractory obsessive-compulsive disorder with comorbid major depressive disorder.
Use of right orbitofrontal repetitive transcranial magnetic stimulation (rTMS) augmentation for treatment-refractory obsessive-compulsive disorder with comorbid major depressive disorder.
复制标题
使用右眶额重复经颅磁刺激(rTMS)增强治疗合并重度抑郁症的难治性强迫症。
DOI:
10.1016/j.psychres.2022.114856
复制
发表时间:
2022
影响因子:
11.3
通讯作者:
Leuchter,AndrewF
中科院分区:
文献类型:
--
作者:
Tadayonnejad,Reza;Wilson,AndrewC;Chu,StephanieAnne;Corlier,Juliana;Citrenbaum,Cole;Ngo,ThucDoanP;Hovhannisyan,Emmily;Ginder,NathanielD;Levitt,JenniferG;Wilke,ScottA;Krantz,David;Bari,AusafA;Leuchter,AndrewF
We examined the safety and efficacy of repetitive Transcranial Magnetic Stimulation (rTMS) of the right orbitofrontal cortex (OFC) in patients with refractory obsessive-compulsive disorder (OCD) and comorbid Major Depressive Disorder. All participants (n= 26) received excitatory stimulation of the left dorsolateral prefrontal cortex followed by inhibitory stimulation of bilateral supplementary motor area for 10 sessions. In 18 patients with poor early OCD response, treatment was augmented with OFC inhibitory stimulation after the tenth treatment session. Augmentation with OFC stimulation was well-tolerated, and associated with further alleviation of both OCD and depression symptoms, particularly in individuals with more severe illnesses.